358.00p+3.00 (+0.85%)21 Jun 2024, 16:42
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Worldwide Healthcare Trust PLC Shares News & Articles

RTW Biotech Opportunities has a great track record which isn't reflected in a wide discount to net asset value

Since inception in October 2019 RTW Biotech Opportunities (RTW) has delivered 65.3% growth in NAV (net asset value), smashing the performance of the Russell 2000 Biotech index which is down 0.7% as well as the NBI (Nasdaq Biotech Index) which is up 20.6% over the same period.Despite the superior performance to the benchmark and peers, the shares trade at an unwarranted 23% discount to NAV, represe

Biotech companies in demand as pharmaceutical companies spend billions on takeovers

With so much macroeconomic uncertainty, the recent mergers and acquisitions spree has lost momentum apart from one sector.Big pharmaceutical firms are awash with cash, yet patent cliffs (expiration of patent protection) present challenges which can be partially fixed by buying smaller biotech firms with products almost ready to go to market.International Biotechnology Trust's (IBT) Ailsa Craig and

Grab a slice of top performing Bellevue Healthcare Trust at a discount to NAV

The Bellevue Healthcare Trust (BBH) has built an enviable track record since launching in 2016. Shares believes the 5.6% discount to NAV (net asset value) presents investors with an attractive entry point.The trust has delivered three-and five-year total returns in NAV of 70.3% and 91.8% respectively, comfortably beating its benchmark (MSCI World Healthcare) returns of 48.6% and 71.2%.Dividends ha
Showing 1 to 20 of 30